Joint Nordic Procurement 2028
Buyer
Name—
Country—
Published2026-07-01
Deadline—
Value
Estimated—
Awarded—
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
This Prior Information Notice is solely a general briefing about the upcoming tender between Amgros I/S in Denmark, Landspitali in Iceland, Sykehusinnkjøp in Norway, Region Skåne in Sweden and HUS Group in Finland. Regarding the section about Notice Information, please note that the tender notices for the pharmaceuticals included in the Joint Nordic Procurement 2028 will be published ultimo 2026, and the date listed under the section about Notice Information is only indicative. Amgros, Landspitali, Sykehusinnkjøp, Region Skåne and HUS Group will hold individual supplier meetings in August, September and October 2026 for the suppliers whom are interested. The meetings will provide general information about Joint Nordic Procurement process and setup. Amgros, Landspitali, Sykehusinnkjøp, Region Skåne and HUS Group encourages everyone who may participate in the Joint Nordic Tender 2028 to book a meeting. Further information about the supplier meetings and booking will be available on Amgros' Supplier and Tender Portal, Landspitali website, Sykehusinnkjøp website, Region Skåne website and HUS Group website no later than August 2026.
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-06-03 | Catheter locks for the health trusts in Helse Vest | SYKEHUSINNKJØP HF NO | 89% |
| 2026-07-09 | Invitation to a supplier conference for a coming procurement of multi-disciplinary specialised drug treatment (TSB) | HELSE SØR-ØST RHF NO | 89% |
| 2026-07-01 | Urological products for the health authorities in Helse Nord | SYKEHUSINNKJØP HF NO | 89% |
| 2026-07-17 | IVF-EQUIPMENT | — | 88% |
| 2026-07-09 | Analysis, research and consultancy services within ICT for health companies in Helse Sør-Øst | SYKEHUSINNKJØP HF NO | 88% |
| 2026-08-14 | REQUEST FOR INFORMATION: HUS 364-2026 Osseointegrated implant systems | HUS Group FI | 88% |